Presence of glyceraldehyde-derived advanced glycation end-products in the liver of insulin-resistant mice

International Journal for Vitamin and Nutrition Research

Volumn 83, Issue 2, 2013, Pages 137-141

  Ebata, Yu ^a   Takino, Junichi ^b   Tsuchiya, Hiroyuki ^a,e   Sakabe, Tomohiko ^c   Ikeda, Yoshito ^a   Hama, Susumu ^a   Kogure, Kentaro ^a   Takeuchi, Masayoshi ^d   Shiota, Goshi ^c  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d KANAZAWA MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

Advanced glycation end products; All trans retinoic acid; Fructose; Glyceraldehyde; Insulin resistance

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIBODY; FRUCTOSE; GLYCERALDEHYDE; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIVER; MOLECULAR WEIGHT; MOUSE; NONHUMAN;

ADVANCED GLYCATION END-PRODUCTS; ALL-TRANS-RETINOIC ACID; FRUCTOSE; GLYCERALDEHYDE; INSULIN RESISTANCE;

ANIMALS; GLYCERALDEHYDE; GLYCOSYLATION END PRODUCTS, ADVANCED; INSULIN RESISTANCE; LIVER; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; TRETINOIN;

EID: 84894357455     PISSN: 03009831     EISSN: 16642821     Source Type: Journal    
DOI: 10.1024/0300-9831/a000150     Document Type: Article

References (9)

1. Verrijken, A., Francque, S. and Van Gaal, L. (2008) The metabolic syndrome and the liver. Acta Gastroenterol. Belg. 71, 48.
2. Takeuchi, M., Takino, J. and Yamagishi, S. (2010) Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy. Curr. Drug Targets 11, 1468-1482.
3. Koenig, R. J., Peterson, C. M., Jones, R. L., Saudek, C., Lehrman, M. and Cerami, A. (1976) Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N. Engl. J. Med. 295, 417-420.
4. Takino, J., Kobayashi, Y. and Takeuchi, M. (2010) The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity. J. Gastroenterol. 45, 646-655,
5. Hyogo, H., Yamagishi, S., Iwamoto, K., Arihiro, K., Takeuchi, M., Sato, T., Ochi, H., Nonaka, M., Nabeshima, Y., Inoue, M., Ishitobi, T., Chayama, K. and Tazuma, S. (2007) Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 22, 1112-1119.
6. Kimura, Y., Hyogo, H., Yamagishi, S., Takeuchi, M., Ishitobi, T., Nabeshima, Y., Arihiro, K. and Chayama, K. (2010) Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH. J. Gastroenterol. 45, 750-757.
7. Tsuchiya, H., Ikeda, Y., Ebata, Y., Kojima, C., Katsuma, R., Tsuruyama, T., Sakabe, T., Shomori, K., Komeda, N., Oshiro, S., Okamoto, H., Takubo, K., Hama, S., Shudo, K., Kogure, K. and Shiota, G. (2012) Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice. Hepatology 56, 1319-1330.
8. Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., McGahan, J. P., Seibert, A., Krauss, R. M., Chiu, S., Schaefer, E. J., Ai, M., Otokozawa, S., Nakajima, K., Nakano, T., Beysen, C., Hellerstein, M. K., Berglund, L. and Havel, P. J. (2009) Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 119, 1322-1334.
9. Lustig, R. H. (2010) Fructose: metabolic, hedonic, and societal parallels with ethanol. J. Am. Diet Assoc. 110, 1307-1321.